- Diagnostics
- Friday, 05 Jun 2020
Japan to have coronavirus vaccines in use by June 2021
Drugmakers around the world are scrambling to develop a treatment or vaccine for COVID-19, the respiratory disease caused by the highly infectious new coronavirus which has so far killed nearly 400,000 people worldwide.
“We will be securing production facilities in parallel with expedited vaccine development,” Japan’s Health Minister Katsunobu Kato told reporters as he outlined plans to bring vaccines into use by the end of the first half of 2021.
Usually, plants for actual vaccine production are arranged only after the successful completion of development.
The Japanese government has earmarked 146 billion yen ($1.34 billion) for vaccine production and distribution in the second extra budget that Prime Minister Shinzo Abe’s cabinet approved last month.
Japanese pharmaceutical firms developing coronavirus vaccines include Shionogi & Co and AnGes Inc.
Related Industry Updates
Zebra Medical Vision Secures FDA Clearance in Oncology
Jul 27, 2020
United Global Alliance Partners With Acumen Research Laboratories to Distribute Novel Coronavirus Diagnostic Test Kits
Apr 07, 2020
North America Cancer Tissue Diagnostics Market Trends, Demand, Share, Analysis To 2027 By Leading Players Bio Rad Laboratories Inc., Abbott, Enzo Life Sciences, Inc., Cancer Genetics Inc.
Dec 04, 2020
Breakthrough Study Makes Cancer Detection Possible With a Simple Blood Test; Introduces a New Systemic Hallmark of Cancer
Feb 07, 2020
OPKO Health's BioReference Laboratories in Partnership with New York State Initiates Testing for COVID-19 Antibodies
Apr 30, 2020
Phosphorus Announces In-Home COVID-19 Viral And Antibody Testing Service In New York Metropolitan Area
May 19, 2020
Quest Diagnostics Begins to Perform COVID-19 Antibody Testing
Apr 22, 2020
Follow us on
